Symbol="ZYME"
AssetType="Common Stock"
Name="Zymeworks Inc. Common Stock"
Description="Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops and markets biotherapeutic products for the treatment of cancer. The company is headquartered in Vancouver, Canada."
CIK="1937653"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="524280000"
EBITDA="180716000"
PERatio="2.971"
PEGRatio="0"
BookValue="7.39"
DividendPerShare="0"
DividendYield="0"
EPS="2.75"
RevenuePerShareTTM="6.71"
ProfitMargin="0.387"
OperatingMarginTTM="0.392"
ReturnOnAssetsTTM="0.212"
ReturnOnEquityTTM="0.457"
RevenueTTM="446144000"
GrossProfitTTM="203779000"
DilutedEPSTTM="2.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="17.57"
AnalystTargetPrice="14.07"
TrailingPE="2.971"
ForwardPE="-"
PriceToSalesRatioTTM="13.31"
PriceToBookRatio="1.782"
EVToRevenue="5.89"
EVToEBITDA="-0.815"
Beta="0.962"
num_52WeekHigh="10.8"
num_52WeekLow="4.11"
num_50DayMovingAverage="8.67"
num_200DayMovingAverage="8.14"
SharesOutstanding="64171000"
DividendDate="None"
ExDividendDate="None"
symbol="ZYME"
open="8.30"
high="8.34"
low="7.89"
price="7.90"
volume="356863.00"
latest_trading_day="2023-07-14"
previous_close="8.31"
change="-0.41"
change_percent="-4.9338%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="20"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="80"
Volume_recent_avg="639144"
Change_recent_avg="-0.03"
Delta_recent_avg="0.44"
Variance_recent_avg="0.22"
Change_ratio_recent_avg="-0.36"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="80"
Aroon_momentum_negative="20"
image_negative_thumbnail_id_1="1108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_negative_thumbnail_id_2="106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_neutral_thumbnail_id_1="525"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="679"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0029.jpeg"
image_positive_thumbnail_id_2="664"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0044.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
